The location of a broken bone can significantly impact the long-term health outcomes of older individuals, according to the new research findings to be presented at the Endocrine Society (ENDO) 2020 Annual Scientific Sessions.
An artificial intelligence tool trained to pinpoint patients with broken bones who are also at risk for osteoporosis outperforms radiologists who manually read the reports, a new study has found.
Screening for hypothyroidism should be considered for patients with alkaptonuria, according to recent study findings.
New research from a team of European investigators suggests age at the onset of puberty could serve as an independent risk factor for type 2 diabetes (T2D).
What is the role of ACE inhibition or angiotensin receptor blockers (ARBs) within regard to the novel coronavirus (COVID-19)?
Transplanted hearts are protected by the diabetes drug Metformin, when the recipient is diabetic a study in the Journal of the American College of Cardiology finds.
In the face of the worldwide coronavirus (COVID-19) pandemic, 4 of the largest cardiology organizations are advising patients receiving treatment with ACE inhibitors (ACE-i) and angiotensin receptor blockers (ARBs) they should not be discontinuing treatment unless it is recommended by their physician.
Until a few weeks ago, telemedicine was primarily seen as a means to improve access to specialty care, reduce healthcare costs and boost patient engagement. And while it has certainly gained traction over the last several years, it still accounted for an extremely small number of total patient encounters, was largely seen as adjunct to traditional in-person clinical care, and restrictions by payers made reimbursements difficult. Combined, these factors largely curtailed the widespread adoption of the virtual practice model. And then came the Coronavirus.
Physicians and patients should continue treatment with their usual anti-hypertensive or diabetes management therapy, says the European Society of Cardiology (ESC). There is no evidence that ACEi or ARBs, drugs which upregulate Angiotensin Converting Enzyme (ACE), increase the risk of contracting COVID-19, the society said in a statement published March 13.
For patients in need of surgery, theres one more way the Coronavirus pandemic may affect them —a shortage of blood.